Brevan Howard Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Brevan Howard Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$502K	Buy
2024 Q4	$606K	Buy
2024 Q3	$455K	Sell
2024 Q2	$644K	Sell
2024 Q1	$1.39M	Buy
2023 Q4	$777K	Buy
2023 Q3	$227K	Buy